{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T20:51:27Z","timestamp":1780087887486,"version":"3.54.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.radonc.2014.06.013","type":"journal-article","created":{"date-parts":[[2014,7,3]],"date-time":"2014-07-03T21:45:41Z","timestamp":1404423941000},"page":"77-82","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"title":["Focal salvage iodine-125 brachytherapy for prostate cancer recurrences after primary radiotherapy: A retrospective study regarding toxicity, biochemical outcome and quality of life"],"prefix":"10.1016","volume":"112","author":[{"given":"Max","family":"Peters","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Metha","family":"Maenhout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochem R.N.","family":"van der Voort van Zyp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marinus A.","family":"Moerland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maaike R.","family":"Moman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lotte M.G.","family":"Steuten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marijke J.H.","family":"van Deursen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"van Vulpen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2014.06.013_b0005","doi-asserted-by":"crossref","first-page":"6992","DOI":"10.1200\/JCO.2005.01.2906","article-title":"Predictors of prostate cancer-specific mortality after radical prostatectomy or radiation therapy","volume":"23","author":"Zhou","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2014.06.013_b0010","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1200\/JCO.2005.02.111","article-title":"Outcome predictors for the increasing PSA state after definitive external-beam radiotherapy for prostate cancer","volume":"23","author":"Zelefsky","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2014.06.013_b0015","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.1200\/JCO.2002.03.061","article-title":"Determinants of prostate cancer-specific survival after radiation therapy for patients with clinically localized prostate cancer","volume":"20","author":"D\u2019Amico","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2014.06.013_b0020","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/cncr.23161","article-title":"Cancer of the Prostate Strategic Urological Research Endeavor (CaPSURE). Treatment failure after primary and salvage therapy for prostate cancer: likelihood, patterns of care, and outcomes","volume":"112","author":"Agarwal","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2014.06.013_b0025","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1464-410X.2011.10827.x","article-title":"Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group","volume":"109","author":"Grimm","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.radonc.2014.06.013_b0030","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.ijrobp.2009.03.049","article-title":"Long-term biochemical and survival outcome of 921 patients treated with I-125 permanent prostate brachytherapy","volume":"76","author":"Hinnen","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2014.06.013_b0035","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ijrobp.2006.08.056","article-title":"Multi-institutional analysis of long-term outcome for stages T1\u2013T2 prostate cancer treated with permanent seed implantation","volume":"67","author":"Zelefsky","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2014.06.013_b0040","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0360-3016(02)02795-5","article-title":"Analysis of intraprostatic failures in patients treated with hormonal therapy and radiotherapy: implications for conformal therapy planning","volume":"53","author":"Cellini","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2014.06.013_b0045","doi-asserted-by":"crossref","first-page":"e787","DOI":"10.1016\/j.ijrobp.2011.11.030","article-title":"Does local recurrence of prostate cancer after radiation therapy occur at the site of primary tumor? Results of a longitudinal MRI and MRSI study","volume":"82","author":"Arrayeh","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2014.06.013_b0050","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ijrobp.2007.03.065","article-title":"Clinically significant prostate cancer local recurrence after radiation therapy occurs at the site of primary tumor: magnetic resonance imaging and step-section pathology evidence","volume":"69","author":"Pucar","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2014.06.013_b0055","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nm.1944","article-title":"Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer","volume":"15","author":"Liu","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.radonc.2014.06.013_b0060","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0090-4295(02)01728-4","article-title":"Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens","volume":"60","author":"Wise","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.radonc.2014.06.013_b0065","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1056\/NEJMcibr0905562","article-title":"The index lesion and the origin of prostate cancer","volume":"361","author":"Ahmed","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2014.06.013_b0070","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1464-410X.2009.08715.x","article-title":"Current salvage methods for recurrent prostate cancer after failure of primary radiotherapy","volume":"105","author":"Kimura","year":"2010","journal-title":"BJU Int"},{"key":"10.1016\/j.radonc.2014.06.013_b0075","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1002\/cncr.22941","article-title":"Patient selection, cancer control, and complications after salvage local therapy for postradiation prostate-specific antigen failure: a systematic review of the literature","volume":"110","author":"Nguyen","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2014.06.013_b0080","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00345-012-0928-8","article-title":"Patterns of outcome and toxicity after salvage prostatectomy, salvage cryosurgery and salvage brachytherapy for prostate cancer recurrences after radiation therapy: a multi-center experience and literature review","volume":"31","author":"Peters","year":"2013","journal-title":"World J Urol"},{"key":"10.1016\/j.radonc.2014.06.013_b0085","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1007\/s00330-011-2377-y","article-title":"ESUR prostate MR guidelines 2012","volume":"22","author":"Barentsz","year":"2012","journal-title":"Eur Radiol"},{"key":"10.1016\/j.radonc.2014.06.013_b0090","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ijrobp.2007.06.029","article-title":"Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy","volume":"70","author":"Haider","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2014.06.013_b0095","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0167-8140(00)00287-5","article-title":"I-125 implantation for localized prostate cancer: the Utrecht University experience","volume":"57","author":"Battermann","year":"2000","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2014.06.013_b0100","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.radonc.2007.01.014","article-title":"Tumour and target volumes in permanent prostate brachytherapy: a supplement to the ESTRO\/EAU\/EORTC recommendations on prostate brachytherapy","volume":"83","author":"Salembier","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2014.06.013_b0105","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S0895-4356(98)00097-3","article-title":"Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations","volume":"51","author":"Aaronson","year":"1998","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.radonc.2014.06.013_b0110","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.radonc.2014.06.013_b0115","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1016\/j.ejca.2008.07.030","article-title":"An international field study of the EORTC QLQ-PR25: a questionnaire for assessing the health-related quality of life of patients with prostate cancer","volume":"44","author":"van Andel","year":"2008","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.radonc.2014.06.013_b0120","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1200\/JCO.1998.16.1.139","article-title":"Interpreting the significance of changes in health-related quality-of-life scores","volume":"16","author":"Osoba","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2014.06.013_b0125","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.urology.2008.03.040","article-title":"Partial salvage cryoablation of the prostate for recurrent prostate cancer after radiotherapy failure","volume":"72","author":"Eisenberg","year":"2008","journal-title":"Urology"},{"key":"10.1016\/j.radonc.2014.06.013_b0130","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/bju.12151","article-title":"Salvage focal and salvage total cryoablation for locally recurrent prostate cancer after primary radiation therapy","volume":"112","author":"de Castro Abreu","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.radonc.2014.06.013_b0135","doi-asserted-by":"crossref","first-page":"4148","DOI":"10.1002\/cncr.27394","article-title":"Focal salvage therapy for localized prostate cancer recurrence after external beam radiotherapy: a pilot study","volume":"118","author":"Ahmed","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2014.06.013_b0140","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/pros.20242","article-title":"Pilot study of radiofrequency interstitial tumor ablation (RITA) for the treatment of radio-recurrent prostate cancer","volume":"65","author":"Shariat","year":"2005","journal-title":"Prostate"},{"key":"10.1016\/j.radonc.2014.06.013_b0145","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ijrobp.2012.04.028","article-title":"Feasibility of MR imaging\/MR spectroscopy-planned focal partial salvage permanent prostate implant (PPI) for localized recurrence after initial PPI for prostate cancer","volume":"85","author":"Hsu","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2014.06.013_b0150","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1148\/radiol.13121291","article-title":"MR Imaging-guided focal cryoablation in patients with recurrent prostate cancer","volume":"268","author":"Bomers","year":"2013","journal-title":"Radiology"},{"key":"10.1016\/j.radonc.2014.06.013_b0165","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.juro.2006.11.069","article-title":"The anatomical and pathological characteristics of irradiated prostate cancers may influence the oncological efficacy of salvage ablative therapies","volume":"177","author":"Huang","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.radonc.2014.06.013_b0160","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.1200\/JCO.2008.20.3497","article-title":"Three-dimensional prostate mapping biopsy has a potentially significant impact on prostate cancer management","volume":"27","author":"Onik","year":"2009","journal-title":"J Clin Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814014002722?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814014002722?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T11:27:38Z","timestamp":1565609258000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814014002722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0167814014002722"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2014.06.013","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Focal salvage iodine-125 brachytherapy for prostate cancer recurrences after primary radiotherapy: A retrospective study regarding toxicity, biochemical outcome and quality of life","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2014.06.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}